Respiratory Disease News and Research

RSS

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

For two years now, the novel coronavirus SARS-CoV-2 has ravaged populations the world over. Some researchers believe that the virus will mutate toward less harmless variants.

19 Apr 2022

Study reveals natural infection of pangolins with human RSV

A new study aimed to determine whether humans were able to transmit RSV to Malayan pangolins.

13 Apr 2022

CDC report on Omicron infections soon after Delta

A new study identifies ten patients with confirmed SARS-CoV-2 Omicron variant infections within 90 days of a previous Delta variant infection.

10 Apr 2022

Tulane researchers show how COVID-19 affects the central nervous system

COVID-19 patients commonly report having headaches, confusion and other neurological symptoms, but doctors don't fully understand how the disease targets the brain during infection.

1 Apr 2022

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

A new study shows that multiple variants of this virus may coinfect the same patient, using both genomic sequencing data and computational models.

30 Mar 2022

The relationship between circadian misalignment and the risk of COVID-19 infection

An interesting new study links changes in the daily rhythms of the human body with the risk of COVID-19.

29 Mar 2022

Understanding how coronavirus, RS virus and rhinovirus affect children

When Inger Heimdal started studying the coronavirus in children in 2014, not many people thought the topic sounded particularly exciting.

18 Mar 2022

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

For World Sleep Day 2022, News-Medical speaks to Max Sieghold, Co-Founder and CFO of Sleepiz, about their technology and its ability to diagnose sleep apnea/

18 Mar 2022

Impact of new COVID vaccinations as novel variants emerge

Researchers explores the changing value of COVID-19 vaccines in a scenario of dynamic immunity and rapidly evolving variants of concern.

17 Mar 2022

Can cardiac biomarkers determine COVID-19 prognosis?

Researchers review prognostic cardiac biomarkers in COVID-19 patients.

15 Mar 2022

Study finds elevated inflammation in macrophages months after mild COVID-19

There is a lack of understanding as to why some people suffer from long-lasting symptoms after COVID-19 infection.

15 Mar 2022

The effect of SARS-CoV-2 infection on patients with a history of atrial fibrillation

In a new study, scientists have evaluated if atrial fibrillation could be regarded as a comorbidity in relation to SARS-CoV-2 infection.

15 Mar 2022

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Researchers analyze the available scientific evidence supporting vitamin D as a neuroprotective agent against the neurological sequelae of COVID-19.

14 Mar 2022

At-home test for influenza is as accurate as rapid diagnostic testing in clinical settings

Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings, according to a recently published, peer-reviewed study.

11 Mar 2022

New antimicrobial technology for air filters can kill bacteria, fungi and viruses in seconds

Researchers at the University of Birmingham working in partnership with firms NitroPep Ltd and Pullman AC have developed new antimicrobial technology for air filters which can in seconds kill bacteria, fungi and viruses including SARS-CoV-2 - providing a potential solution to prevent the spread of airborne infections.

9 Mar 2022

Three new drug companies join the COVIDRIVE consortium to study vaccine effectiveness

Three new drug companies (Moderna, Novavax and Valneva) have joined the COVIDRIVE consortium, becoming partners of this project coordinated by the Vaccine Research Department of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (Fisabio), an affiliate of the Conselleria de Sanitat Universal i Salut Pública, along with the company specialized in pharmacovigilance and epidemiology, P95.

8 Mar 2022

Respiratory Disease News and Research

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

Study reveals natural infection of pangolins with human RSV

CDC report on Omicron infections soon after Delta

Tulane researchers show how COVID-19 affects the central nervous system

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

The relationship between circadian misalignment and the risk of COVID-19 infection

Understanding how coronavirus, RS virus and rhinovirus affect children

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

Impact of new COVID vaccinations as novel variants emerge

Can cardiac biomarkers determine COVID-19 prognosis?

Study finds elevated inflammation in macrophages months after mild COVID-19

The effect of SARS-CoV-2 infection on patients with a history of atrial fibrillation

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

At-home test for influenza is as accurate as rapid diagnostic testing in clinical settings

New antimicrobial technology for air filters can kill bacteria, fungi and viruses in seconds

Three new drug companies join the COVIDRIVE consortium to study vaccine effectiveness

Could oropharyngeal microflora predict COVID-19 patients' need for respiratory support?

A promising new vaccine for SARS-CoV-2 and influenza

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

Mathematical model suggests a clue as to when COVID-19 pandemic will turn into an endemic

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News